FEATURE ARTICLES
Determining whether a drug manufacturing environment is stable, drifting, or developing a recurring loss-of-control signal requires integrated trend evaluation.
- FDA Rethinks Skin Sensitization Testing For Generic Transdermal And Topical Delivery Systems
- How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
- The EU Overhauls Pharma Laws: What You Need To Know
- Modulus Brings Home Top Award At 2026 FOYAs
- Designing Pharma Facilities For Change, Not Just Capacity
- September 2026 — CDMO Opportunities And Threats Report
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2185496754-green-sustainability-graph-leaf-business-growth]( "Sustainability In Small Molecule API Manufacturing")
Sustainability In Small Molecule API ManufacturingRedesigning chemical processes with green chemistry principles can cut emissions, reduce waste, and improve efficiency. See how smarter synthesis and digital tools enable sustainable API manufacturing.
-
Sterile Filtration Of Budesonide As A Preferred Sterilization Strategy5/19/2026
Accelerate development of high‑quality inhalation therapies by leveraging sterile‑filtered budesonide to safeguard purity, stability, and patient safety.
-
Beyond Flexibility: The Strategic Value Of Single-Use In Virus Filtration7/24/2026
Single-use virus filtration offers key strategic benefits beyond operational convenience, enabling faster time to market, scalable manufacturing, and flexible supply chains for biopharma production.
-
The Role Of A Consulting Firm In The IND Process6/10/2025
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Robust Database Characterizes And Optimizes Product Development8/29/2026
Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.
-
Comparative Evaluation Of NHP And VHP For Isolator Decontamination10/5/2026
Comparative evaluation reveals how optimizing hydrogen peroxide cycle parameters improves pharmaceutical isolator bio-decontamination efficiency while maintaining Annex 1 sterility compliance.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Particle Data Collection And Interpretation For ISO Cleanrooms
- Intact- And Peptide-Level Characterization Of T-DM1 In Vitro
- Meeting Annex 1: A Proactive Approach To Regulatory Compliance
- Scale-Up Approaches For Culturing Adherent Cells
- Improving API Solubility Using Spray Drying With Polyvinyl Alcohol
NEWSLETTER ARCHIVE
- 11.06.26 -- Smarter Strategies For Complex Protein Manufacturing
- 11.05.26 -- Reduce Risk From Drug Formulation Through Commercial Launch
- 11.05.26 -- Designing Modular Facilities For Scalability And Future Technologies
- 11.03.26 -- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- 11.03.26 -- Where Speed Is Lost: Fixing Handoffs In BioPharma Operations
- Modulus Brings Home Top Award At 2026 FOYAs
- Designing Pharma Facilities For Change, Not Just Capacity
- Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up
- Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
- Capturing Tablet Disintegration for Improved OSD Development
NEW FOR OUR READERS
INDUSTRY NEWS
-
![white coupon banner, great topic-GettyImages-2271702407]( "Let Your Voice Help Shape Pharma Manufacturing")
Let Your Voice Help Shape Pharma ManufacturingPharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
![rating service, satisfaction-GettyImages-2221603596]( "ISPE Announces 2026 FOYA Winners")
ISPE Announces 2026 FOYA WinnersThese awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
EDITORIAL COLLECTIONS
Our curated Editorial Collections bring expert insights together in one place, offering practical perspectives and actionable guidance to help you navigate complex decisions and improve performance.
More Editorial CollectionsSUPPLIER NEWS
-
Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence11/3/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs.
-
Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina11/2/2026
Bracco, a global leader in diagnostic imaging, today announced plans to invest $230 million to establish its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. Expected to create 200 jobs, the investment marks a significant milestone in Bracco's global manufacturing strategy, expanding production capacity and strengthening supply chain resilience in the United States, the company's largest market.
-
Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand10/29/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today the further expansion of its integrated bioconjugation manufacturing offering. Lonza is combining the flexibility of mid-scale bioconjugation manufacturing with its previously announced large-scale bioconjugation expansion in Visp (CH), which will now include three multiproduct suites. Together, these capabilities will offer customers a scalable manufacturing pathway from clinical development through commercial supply for antibody-drug conjugates (ADCs) and other bioconjugates.
-
ROSS Portable High Shear Mixing System10/29/2026
-
Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request10/29/2026
Ardena has launched a searchable Biomarker Catalogue on its website, giving sponsors a faster route from biomarker selection to a bioanalysis quote.
